Refresh
Exchange Announcement • 30 Apr 2024 07:54
Exchange Announcement • 26 Apr 2024 14:46
Exchange Announcement • 19 Apr 2024 06:36
Exchange Announcement • 05 Apr 2024 16:49
Exchange Announcement • 20 Mar 2024 11:45
ENTITY
Paradigm Biopharmaceuticals (PAR AU)
Paradigm Biopharmaceuticals (PAR AU)
19
Analysis
Health Care • Australia
Paradigm Biopharmaceuticals Limited operates as a biopharmaceutical company. The Company develops PPS drug to treat respiratory diseases such as allergic asthma, allergic rhinitis, and chronic obstructive pulmonary. Paradigm Biopharmaceuticals offers its services in Australia.
more
x